Episode Details
Back to Episodes
Investing in AI: Benefits, Regulatory Challenges
Published 1 year, 8 months ago
Description
No discussion regarding the future is complete unless AI is incorporated.
In this episode, Konstantina Katcheves of Teva Pharmaceuticals and Sanskriti Thakur of TOWER Capital Group provide their insights on the impact of not only the benefits of the technology but the regulatory challenges and uncertainty surrounding AI.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital